A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal ...

Many forms of cancer are devastating. But pancreatic cancer is one of the most deadly and aggressive forms there is. There are several reasons for this, including its stealthy progression, rapid ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...

Cancer is often perceived as a fate, but what if it could be avoided even before it manifests? Scientists have just taken a significant step in that direction. Their work on mice reveals that ...